Visioneering Technologies Inc. (ASX:VTI)


right-arrow Created with Sketch. 0 (0%)
MCAP $21.62M
Last trade 15.32pm 26/11/2021 20mins delayed

Latest Announcements

10/11/2021VTIVisioneering Technologies Inc.
05/11/2021 Price SensitivePSVTIVisioneering Technologies Inc.
05/11/2021VTIVisioneering Technologies Inc.
05/11/2021 Price SensitivePSVTIVisioneering Technologies Inc.
14/10/2021 Price SensitivePSVTIVisioneering Technologies Inc.
07/10/2021VTIVisioneering Technologies Inc.
23/09/2021 Price SensitivePSVTIVisioneering Technologies Inc.
20/08/2021 Price SensitivePSVTIVisioneering Technologies Inc.

Company Overview

Visioneering Technologies, Inc is an eye care company. The Company is engaged in designing, manufacturing, selling and distributing contact lenses. It offers NaturalVue Multifocal contact lens for the treatment of myopia. Its product, the NaturalVue Multifocal (etafilcon A) 1 Day Contact Lens (NaturalVue MF), is used by patient populations with vision needs. It provides its product for children who have blurry distance vision through their childhood and adolescence, a condition called myopia progression. It also offers its products for persons over the age of 40 who have myopia and are losing their ability to see near objects, a condition called presbyopia. It also sells NaturalVue Sphere, which is a contact lens for the correction of blurry distance vision. It is also developing products for those with astigmatism. Its products are used by Eye Care Professionals (ECPs) to treat myopia in children and middle-age and older adults with correction of near and distance vision.

VTI in the news

Visioneering Technologies (VTI) has unveiled an enhanced contact lens at the American…
Visioneering Technologies (VIT) closes red following the release of its quarterly financial…
Medical device company Visioneering Technologies (VTI) has closed its security purchase plan…
Eyesight specialist Visioneering Technologies (VTI) has received commitments for an oversubscribed $22…

Search Previous Announcements